{
  "ptid_time": "141_S_4160_2011-12-05",
  "img_path": "/data/qiuhui/data/adni/images/141_S_4160/2011-12-05/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 66,518 mm³, 72.7% above the reference mean. With a Z-score of 1.74 (95.9th percentile), this represents moderate enlargement; hippocampal volume measures 6,811 mm³, 9.9% below the reference mean. With a Z-score of -0.97 (16.7th percentile), this represents normal volume ; whole brain volume measures 1,083,260 mm³, 0.4% above the reference mean. With a Z-score of 0.05 (51.9th percentile), this represents normal volume ; entorhinal cortex volume measures 2,562 mm³, 37.5% below the reference mean. With a Z-score of -2.54 (0.5th percentile), this represents significant atrophy; fusiform gyrus volume measures 14,575 mm³, 22.6% below the reference mean. With a Z-score of -1.93 (2.7th percentile), this represents moderate atrophy; middle temporal gyrus volume measures 19,834 mm³, 7.1% below the reference mean. With a Z-score of -0.63 (26.3th percentile), this represents normal volume . ",
  "text_data": "Age is 74.1 years. Gender is Male. Education: 12 years. Handedness: Left. Race: White. Medical history: Psychiatric; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Endocrine-Metabolic; Hematopoietic-Lymphatic; Smoking; Malignancy; Major Surgical Procedures. MMSE: 25.0. MoCA: 21.0. Logical Memory: 7.0. Laboratory findings: Vitamin B12: 918.00 (significant elevated); Total Bilirubin: 1.30 (profound elevated); Serum Glucose: 68.00 (significant reduced); Direct Bilirubin: 0.30 (significant elevated). APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 0.96 SUVR (mild reduced); Amyloid beta: 1035.00 pg/mL (normal ); Total tau: 126.30 pg/mL (mild reduced); Phosphorylated tau: 10.84 pg/mL (mild reduced). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient shows significant atrophy in the entorhinal cortex and moderate atrophy in the fusiform gyrus, both key regions affected in Alzheimer's disease (AD). However, hippocampal volume is normal, and amyloid biomarkers (Aβ, AV45) are not elevated, which is atypical for AD. The MMSE (25) and MoCA (21) scores suggest mild cognitive impairment (MCI), but the lack of amyloid pathology lowers confidence in an AD diagnosis.  \n\n**Diagnosis:** **MCI** (likely non-amyloid subtype, possibly due to another neurodegenerative or vascular etiology).  \n\n**Confidence:** **Medium** (due to conflicting imaging and biomarker findings).",
  "timestamp": "2025-07-26T17:02:01.340128"
}